Molecular pathogenesis of polymerase gamma-related neurodegeneration

Annals of Neurology

Volumn 76, Issue 1, 2014, Pages 66-81

  Tzoulis, Charalampos ^a,b   Tran, Gia Tuong ^b   Coxhead, Jonathan ^c,d   Bertelsen, Bjørn ^a   Lilleng, Peer K ^a   Balafkan, Novin ^b   Payne, Brendan ^c   Miletic, Hrvoje ^a,b   Chinnery, Patrick F ^c   Bindoff, Laurence A ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Natl Inst for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Disease Newcastle University ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE GAMMA; FORMALDEHYDE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADOLESCENT; AGED; ARTICLE; BRAIN CORTEX LESION; BRAIN TISSUE; CELL RESPIRATION; CLINICAL ARTICLE; COMPLEX I DEFICIENCY; CONTROLLED STUDY; DISEASE DURATION; DOPAMINERGIC NERVE CELL; EPILEPTIC FOCUS; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MICRODISSECTION; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL GENOME; MOLECULAR PATHOLOGY; NERVE DEGENERATION; POINT MUTATION; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ADOLESCENT; ADULT; CEREBELLUM; CEREBRAL CORTEX; CHILD; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; HUMANS; INFANT; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MUTATION; NERVE DEGENERATION; SUBSTANTIA NIGRA; YOUNG ADULT;

EID: 84904802335     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24185     Document Type: Article

References (31)

1. Van Goethem G, Dermaut B, Lofgren A, et al. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001; 28: 211-212.
2. Trifunovic A, Wredenberg A, Falkenberg M, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417-423.
3. Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004; 364: 875-882.
4. Luoma PT, Eerola J, Ahola S, et al. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology 2007; 69: 1152-1159.
5. Balafkan N, Tzoulis C, Muller B, et al. Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. Mitochondrion 2012; 12: 640-643.
6. Tzoulis C, Tran GT, Schwarzlmuller T, et al. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain 2013; 136 (pt 8): 2393-2404.
7. Hakonen AH, Heiskanen S, Juvonen V, et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005; 77: 430-441.
8. Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006; 129 (pt 7): 1685-1692.
9. Tzoulis C, Neckelmann G, Mork SJ, et al. Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain 2010; 133 (pt 5): 1428-1437.
10. Chan SS, Longley MJ, Copeland WC,. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J Biol Chem 2005; 280: 31341-31346.
11. Chan SS, Longley MJ, Copeland WC,. Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphism in mitochondrial disorders. Hum Mol Genet 2006; 15: 3473-3483.
12. Hakonen AH, Goffart S, Marjavaara S, et al. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 2008; 17: 3822-3835.
13. Zsurka G, Baron M, Stewart JD, et al. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma. J Neuropathol Exp Neurol 2008; 67: 857-866.
14. Lax NZ, Hepplewhite PD, Reeve AK, et al. Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study. J Neuropathol Exp Neurol 2012; 71: 148-161.
15. Lax NZ, Whittaker RG, Hepplewhite PD, et al. Sensory neuronopathy in patients harbouring recessive polymerase gamma mutations. Brain 2012; 135: 62-71.
16. Ferrari G, Lamantea E, Donati A, et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 2005; 128 (pt 4): 723-731.
17. Suomalainen A, Majander A, Haltia M, et al. Multiple deletions of mitochondrial-DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992; 90: 61-66.
18. Uusimaa J, Hinttala R, Rantala H, et al. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus. Epilepsia 2008; 49: 1038-1045.
19. Payne BA, Wilson IJ, Hateley CA, et al. Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat Genet 2011; 43: 806-810.
20. Payne BA, Wilson IJ, Yu-Wai-Man P, et al. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet 2013; 22: 384-390.
21. Kraytsberg Y, Kudryavtseva E, McKee AC, et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006; 38: 518-520.
22. Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006; 38: 515-517.
23. Reeve AK, Krishnan KJ, Elson JL, et al. Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet 2008; 82: 228-235.
24. Elstner M, Muller SK, Leidolt L, et al. Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions. Mol Brain 2011; 4: 43.
25. Kann O, Huchzermeyer C, Kovacs R, et al. Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. Brain 2011; 134 (pt 2): 345-358.
26. Palin EJ, Paetau A, Suomalainen A,. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders. Brain 2013; 136 (pt 8): 2379-2392.
27. Lascano AM, Lemkaddem A, Granziera C, et al. Tracking the source of cerebellar epilepsy: hemifacial seizures associated with cerebellar cortical dysplasia. Epilepsy Res 2013; 105: 245-249.
28. Rodin E,. Paper recordings of ultrafast frequencies in experimental epilepsy. Clin EEG Neurosci 2005; 36: 263-270.
29. Wiest R, Estermann L, Scheidegger O, et al. Widespread grey matter changes and hemodynamic correlates to interictal epileptiform discharges in pharmacoresistant mesial temporal epilepsy. J Neurol 2013; 260: 1601-1610.
30. Sequeira KM, Tabesh A, Sainju RK, et al. Perfusion network shift during seizures in medial temporal lobe epilepsy. PLoS One 2013; 8: e53204.
31. Greijer AE, van der Wall E,. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clinical Pathol 2004; 57: 1009-1014.